PMID- 8625369 OWN - NLM STAT- MEDLINE DCOM- 19960626 LR - 20190909 IS - 0340-7004 (Print) IS - 0340-7004 (Linking) VI - 42 IP - 1 DP - 1996 Jan TI - T cell receptor Vbeta repertoire of tumour-infiltrating lymphocytes in oral squamous-cell carcinoma. PG - 69-70 AB - Oral squamous cell carcinoma (OSCC) are frequently infiltrated by tumour infiltrating lymphocytes (TILs) which may demonstrate specific anti-tumour cytotoxicity. We have used a panel of family-specific primers in reverse-transcriptase (RT)-polymerase chain reactions (PCR) to determine the TCR Vbeta repertoire of TILs in the primary and metastatic tumours in patients with OSCC. We observed a diverse and heterogenous usage of TCR Vbeta genes by TILs in the primary tumours, a scenario not unlike normal oral mucosal lymphocytes. In one patient with a longstanding history of OSCC, the repertoire was restricted. Restricted TCR Vbeta gene usage also occurred in TILs of metastatic tumours. Within individual patients, discrepancies of TCR Vbeta gene usage were also observed between TILs in the primary OSCC and those in metastatic lymph nodes. Work is ongoing to determine the clonality and functional significance of these TILs. FAU - Lim, S H AU - Lim SH AD - Department of Haematology, University of Wales College of Medicine, Heath Park, UK. FAU - Thomas, D W AU - Thomas DW FAU - Coleman, S AU - Coleman S FAU - Stephens, P AU - Stephens P LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Germany TA - Cancer Immunol Immunother JT - Cancer immunology, immunotherapy : CII JID - 8605732 RN - 0 (Receptors, Antigen, T-Cell, alpha-beta) SB - IM MH - Biopsy MH - Carcinoma, Squamous Cell/*pathology MH - Humans MH - Lymph Nodes/pathology MH - Lymphocytes, Tumor-Infiltrating/*ultrastructure MH - Mouth Neoplasms/*pathology MH - Polymerase Chain Reaction/methods MH - Receptors, Antigen, T-Cell, alpha-beta/*analysis MH - Submandibular Gland MH - Transcription, Genetic EDAT- 1996/01/01 00:00 MHDA- 1996/01/01 00:01 CRDT- 1996/01/01 00:00 PHST- 1996/01/01 00:00 [pubmed] PHST- 1996/01/01 00:01 [medline] PHST- 1996/01/01 00:00 [entrez] AID - 10.1007/s002620050253 [doi] PST - ppublish SO - Cancer Immunol Immunother. 1996 Jan;42(1):69-70. doi: 10.1007/s002620050253.